Literature DB >> 20197298

Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia.

Ali Torkamani1, Brian Dean, Nicholas J Schork, Elizabeth A Thomas.   

Abstract

We performed integrated gene coexpression network analysis on two large microarray-based brain gene expression data sets generated from the prefrontal cortex obtained post-mortem from 101 subjects, 47 subjects with schizophrenia and 54 normal control subjects, ranging in age from 19 to 81 years. Twenty-eight modules of coexpressed genes with functional interpretations were detected in both normal subjects and those with schizophrenia. Significant overlap of "case" and "control" module composition was observed, indicating that extensive differences in underlying molecular connectivity are not likely driving pathology in schizophrenia. Modules of coexpressed genes were characterized according to disease association, cell type specificity, and the effects of aging. We find that genes with altered expression in schizophrenia clustered into distinct coexpression networks and that these were associated primarily with neurons. We further identified a robust effect of age on gene expression modules that differentiates normal subjects from those with schizophrenia. In particular, we report that normal age-related decreases in genes related to central nervous system developmental processes, including neurite outgrowth, neuronal differentiation, and dopamine-related cellular signaling, do not occur in subjects with schizophrenia during the aging process. Extrapolating these findings to earlier stages of development supports the concept that schizophrenia pathogenesis begins early in life and is associated with a failure of normal decreases in developmental-related gene expression. These findings provide a novel mechanism for the "developmental" hypothesis of schizophrenia on a molecular level.

Entities:  

Mesh:

Year:  2010        PMID: 20197298      PMCID: PMC2847743          DOI: 10.1101/gr.101956.109

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  40 in total

1.  Age differences in the expression of metabotropic glutamate receptor 1 and inositol 1,4,5-trisphosphate receptor in mouse cerebellum.

Authors:  A Simonyi; J Xia; U Igbavboa; W G Wood; G Y Sun
Journal:  Neurosci Lett       Date:  1998-03-06       Impact factor: 3.046

2.  Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia.

Authors:  Dmitri Tkachev; Michael L Mimmack; Stephen J Huffaker; Margaret Ryan; Sabine Bahn
Journal:  Int J Neuropsychopharmacol       Date:  2007-02-12       Impact factor: 5.176

3.  Postnatal alterations in dopaminergic markers in the human prefrontal cortex.

Authors:  C S Weickert; M J Webster; P Gondipalli; D Rothmond; R J Fatula; M M Herman; J E Kleinman; M Akil
Journal:  Neuroscience       Date:  2006-11-22       Impact factor: 3.590

4.  Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.

Authors:  Sandeep T Patil; Lu Zhang; Ferenc Martenyi; Stephen L Lowe; Kimberley A Jackson; Boris V Andreev; Alla S Avedisova; Leonid M Bardenstein; Issak Y Gurovich; Margarita A Morozova; Sergey N Mosolov; Nikolai G Neznanov; Alexander M Reznik; Anatoly B Smulevich; Vladimir A Tochilov; Bryan G Johnson; James A Monn; Darryle D Schoepp
Journal:  Nat Med       Date:  2007-09-02       Impact factor: 53.440

Review 5.  The myelin-pathogenesis puzzle in schizophrenia: a literature review.

Authors:  G Karoutzou; H M Emrich; D E Dietrich
Journal:  Mol Psychiatry       Date:  2007-10-09       Impact factor: 15.992

6.  Abnormalities of regional distribution of cerebral vasculature in schizophrenia detected by dynamic susceptibility contrast MRI.

Authors:  B M Cohen; D Yurgelun-Todd; C D English; P F Renshaw
Journal:  Am J Psychiatry       Date:  1995-12       Impact factor: 18.112

Review 7.  White matter changes in schizophrenia: evidence for myelin-related dysfunction.

Authors:  Kenneth L Davis; Daniel G Stewart; Joseph I Friedman; Monte Buchsbaum; Philip D Harvey; Patrick R Hof; Joseph Buxbaum; Vahram Haroutunian
Journal:  Arch Gen Psychiatry       Date:  2003-05

8.  Normal human aging and early-stage schizophrenia share common molecular profiles.

Authors:  Bin Tang; Wei-li Chang; Caroline M Lanigan; Brian Dean; J Gregor Sutcliffe; Elizabeth A Thomas
Journal:  Aging Cell       Date:  2009-02-26       Impact factor: 9.304

9.  Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function.

Authors:  P R Maycox; F Kelly; A Taylor; S Bates; J Reid; R Logendra; M R Barnes; C Larminie; N Jones; M Lennon; C Davies; J J Hagan; C A Scorer; C Angelinetta; M T Akbar; T Akbar; S Hirsch; A M Mortimer; T R E Barnes; J de Belleroche
Journal:  Mol Psychiatry       Date:  2009-03-03       Impact factor: 15.992

10.  Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation.

Authors:  Micaela Zonta; María Cecilia Angulo; Sara Gobbo; Bernhard Rosengarten; Konstantin-A Hossmann; Tullio Pozzan; Giorgio Carmignoto
Journal:  Nat Neurosci       Date:  2003-01       Impact factor: 24.884

View more
  79 in total

1.  Gene network effects on brain microstructure and intellectual performance identified in 472 twins.

Authors:  Ming-Chang Chiang; Marina Barysheva; Katie L McMahon; Greig I de Zubicaray; Kori Johnson; Grant W Montgomery; Nicholas G Martin; Arthur W Toga; Margaret J Wright; Paul Shapshak; Paul M Thompson
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

2.  Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence.

Authors:  Igor Ponomarev; Shi Wang; Lingling Zhang; R Adron Harris; R Dayne Mayfield
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

3.  Alternative transcription exceeds alternative splicing in generating the transcriptome diversity of cerebellar development.

Authors:  Sharmistha Pal; Ravi Gupta; Hyunsoo Kim; Priyankara Wickramasinghe; Valérie Baubet; Louise C Showe; Nadia Dahmane; Ramana V Davuluri
Journal:  Genome Res       Date:  2011-06-28       Impact factor: 9.043

4.  Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders.

Authors:  S Kim; Y Hwang; M J Webster; D Lee
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

5.  Critical period plasticity-related transcriptional aberrations in schizophrenia and bipolar disorder.

Authors:  Milo R Smith; Ben Readhead; Joel T Dudley; Hirofumi Morishita
Journal:  Schizophr Res       Date:  2018-11-12       Impact factor: 4.939

6.  Transcriptomic Evidence for Alterations in Astrocytes and Parvalbumin Interneurons in Subjects With Bipolar Disorder and Schizophrenia.

Authors:  Lilah Toker; Burak Ogan Mancarci; Shreejoy Tripathy; Paul Pavlidis
Journal:  Biol Psychiatry       Date:  2018-07-21       Impact factor: 13.382

7.  GC-MS metabolic profiling reveals fructose-2,6-bisphosphate regulates branched chain amino acid metabolism in the heart during fasting.

Authors:  Albert Batushansky; Satoshi Matsuzaki; Maria F Newhardt; Melinda S West; Timothy M Griffin; Kenneth M Humphries
Journal:  Metabolomics       Date:  2019-01-28       Impact factor: 4.290

Review 8.  Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders.

Authors:  C Gaiteri; Y Ding; B French; G C Tseng; E Sibille
Journal:  Genes Brain Behav       Date:  2013-12-10       Impact factor: 3.449

9.  Gene expression elucidates functional impact of polygenic risk for schizophrenia.

Authors:  Menachem Fromer; Panos Roussos; Solveig K Sieberts; Jessica S Johnson; David H Kavanagh; Thanneer M Perumal; Douglas M Ruderfer; Edwin C Oh; Aaron Topol; Hardik R Shah; Lambertus L Klei; Robin Kramer; Dalila Pinto; Zeynep H Gümüş; A Ercument Cicek; Kristen K Dang; Andrew Browne; Cong Lu; Lu Xie; Ben Readhead; Eli A Stahl; Jianqiu Xiao; Mahsa Parvizi; Tymor Hamamsy; John F Fullard; Ying-Chih Wang; Milind C Mahajan; Jonathan M J Derry; Joel T Dudley; Scott E Hemby; Benjamin A Logsdon; Konrad Talbot; Towfique Raj; David A Bennett; Philip L De Jager; Jun Zhu; Bin Zhang; Patrick F Sullivan; Andrew Chess; Shaun M Purcell; Leslie A Shinobu; Lara M Mangravite; Hiroyoshi Toyoshiba; Raquel E Gur; Chang-Gyu Hahn; David A Lewis; Vahram Haroutunian; Mette A Peters; Barbara K Lipska; Joseph D Buxbaum; Eric E Schadt; Keisuke Hirai; Kathryn Roeder; Kristen J Brennand; Nicholas Katsanis; Enrico Domenici; Bernie Devlin; Pamela Sklar
Journal:  Nat Neurosci       Date:  2016-09-26       Impact factor: 24.884

10.  Ontogenetic de novo copy number variations (CNVs) as a source of genetic individuality: studies on two families with MZD twins for schizophrenia.

Authors:  Sujit Maiti; Kiran Halagur Bhoge Gowda Kumar; Christina A Castellani; Richard O'Reilly; Shiva M Singh
Journal:  PLoS One       Date:  2011-03-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.